The immunosuppressive drug mycophenolate mofetil (MMF) has been linked by a researcher to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients, suggests a new report.
The immunosuppressive drug mycophenolate mofetil (MMF) has been linked by a researcher to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients, suggests a new report.